Showing results (1-10 of 19) with videos related to
Sort By:
Pageof 2
Seminars in Hematology|March 22, 2006
Purine analogue-based chemotherapy regimens for second-line therapy in patients with chronic lymphocytic leukemiaNicole Lamanna, Mark A WeissExpert Opinion on Drug Metabolism & Toxicology|August 30, 2008
Pentostatin in chronic lymphocytic leukemiaCraig Sauter, Nicole Lamanna, Mark A WeissTherapeutic Advances in Hematology|February 4, 2014
Liposomal vincristine for relapsed or refractory Ph-negative acute lymphoblastic leukemia: a review of literaturePriyanka Pathak, Rosemary Hess, Mark A WeissCancer|June 23, 2015
Immunotherapy in acute myeloid leukemiaDolores A Grosso, Rosemary C Hess, Mark A WeissScientific Reports|February 2, 2022
Did border closures slow SARS-CoV-2?Mary A Shiraef, Paul Friesen, Lukas Feddern, et al.The American Journal of Surgical Pathology|April 30, 2003
Inflammatory myofibroblastic tumors of the kidney: a clinicopathologic and immunohistochemical study of 12 casesLinda R Kapusta, Mark A Weiss, Jennifer Ramsay, et al.Gene|July 23, 2013
Neanderthal and Denisova genetic affinities with contemporary humans: introgression versus common ancestral polymorphismsRobert K Lowery, Gabriel Uribe, Eric B Jimenez, et al.Cancer|February 6, 2003
Refractory Aspergillus pneumonia in patients with acute leukemia: successful therapy with combination caspofungin and liposomal amphotericinTimothy B Aliff, Peter G Maslak, Joseph G Jurcic, et al.Cancer|January 3, 2013
Treatment of adults with acute lymphoblastic leukemia: do the specifics of the regimen matter?: Results from a prospective randomized trialNicole Lamanna, Leonard T Heffner, Matt Kalaycio, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2003
Pentostatin and cyclophosphamide: an effective new regimen in previously treated patients with chronic lymphocytic leukemiaMark A Weiss, Peter G Maslak, Joseph G Jurcic, et al.Pageof 2